Skip to content

WuXi AppTec Co., Ltd.

Follow

13F filer, CIK 1832424, Shanghai, China

WuXi AppTec Co., Ltd. reported $29,395,037 across 2 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-07.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-058027

Period
2024-03-31
Reported value
$29.4M
Holdings
2
Top 10 weight
100%
New
0
Sold out
3

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMBRX BIOPHARMA INCexited-1,000,000-$14.2M
ADAGreduced-242,794-$680K
PURPLE BIOTECH LTD SPONSORE…exited-194,139-$151K
CSTLexited-6,636-$143K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0001104659-24-058027, largest first. % of portfolio is the value over $29,395,037, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 8,180,678 shares; 2024Q1: 8,180,678 shares 8,180,678$18.2M62.06%0
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not loaded; 2023Q1: not loaded; 2023Q2: not loaded; 2023Q3: not loaded; 2023Q4: 4,225,696 shares; 2024Q1: 3,982,902 shares 3,982,902$11.2M37.94%-242,794Timeline

Sold out in Q1 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AMBRX BIOPHARMA INCAMBRX BIOPHARMA INC1,000,000$14.2Mshares
PURPLE BIOTECH LTD SPONSORE…PURPLE BIOTECH LTD SPONSORED ADR194,139$151Kshares
CSTLCASTLE BIOSCIENCES INC6,636$143Kshares

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-058027 base2024-05-07acceptance time not in the bulk data set